ELAPRASE — SHIRE, approved 2018-11-16 (BLA125151).
4,422 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.